This is a past event. Registration is closed. View other NewYorkBIO events.
Welcome Remarks
Jennifer Hawks Bland

Opening remarks from NewYorkBIO's CEO, Jennifer Hawks Bland

  • Jennifer Hawks Bland (Chief Executive Officer at NewYorkBIO)

    Jennifer Hawks Bland

    Chief Executive Officer at NewYorkBIO
General Session
Dr. Marco Pappagallo•Cindy Steinberg•Michael Oshinsky
  • Dr. Marco Pappagallo (Pain Physician and Developer of Pain Therapeutics)

    Dr. Marco Pappagallo

    Pain Physician and Developer of Pain Therapeutics
  • Cindy Steinberg (National Director of Policy and Advocacy at U.S. Pain Foundation)

    Cindy Steinberg

    National Director of Policy and Advocacy at U.S. Pain Foundation
  • Michael Oshinsky (Program Director of NIH/NINDS)

    Michael Oshinsky

    Program Director of NIH/NINDS
Vision Talk
John Crowley
  • John Crowley (President and CEO of BIO)

    John Crowley

    President and CEO of BIO
Networking Break
Fireside Chat: How Are Patients Benefitting from Federal Programs?
Grant Cale•Dr. Robert Popovian
  • Grant Cale (Senior Director of Strategic Alliances and Issue Advocacy at Bristol Myers Squibb Company)

    Grant Cale

    Senior Director of Strategic Alliances and Issue Advocacy at Bristol Myers Squibb Company
  • Dr. Robert Popovian (Founder of Conquest Advisors)

    Dr. Robert Popovian

    Founder of Conquest Advisors
Panel Discussion:The Talent Within: Creative collaboration with Families, Organizations, and Industry
Claire Judkins•Rick Otis•Jenny Tesler•Eleonora-Tornatore-Mikesh
  • Claire Judkins (Patient Advocacy & Industry Relations Senior Liaison at Acadia Pharmaceuticals)

    Claire Judkins

    Patient Advocacy & Industry Relations Senior Liaison at Acadia Pharmaceuticals
  • Rick Otis (Rett Advocate and Father to Barrett)

    Rick Otis

    Rett Advocate and Father to Barrett
  • Jenny Tesler (Producer)

    Jenny Tesler

    Producer
  • Eleonora-Tornatore-Mikesh (President and CEO of CaringKind)

    Eleonora-Tornatore-Mikesh

    President and CEO of CaringKind
Lunch
Fireside Chat: Investing with a health equity perspective in pharma/biotech companies
Clark Lin•Squire Servance
  • Clark Lin (Partner, Patents and Innovations at Wilson Sonsini Goodrich & Rosati)

    Clark Lin

    Partner, Patents and Innovations at Wilson Sonsini Goodrich & Rosati
  • Squire Servance (Founder and Managing Partner of Syridex Bio)

    Squire Servance

    Founder and Managing Partner of Syridex Bio
Panel Discussion: Loper Bright and the effect of the Supreme Court’s new view on the deference formerly given under the Chevron decision: A boon or bust for life sciences?
Arunabha Bhoumik•Linda Malek•Chris Potts•Anne Li•Kirke Weaver
  • Arunabha Bhoumik (Executive Director and Assistant General Counsel of Regeneron Pharmaceuticals, Inc.)

    Arunabha Bhoumik

    Executive Director and Assistant General Counsel of Regeneron Pharmaceuticals, Inc.
  • Linda Malek (Partner at Crowell & Moring LLP)

    Linda Malek

    Partner at Crowell & Moring LLP
  • Chris Potts (CEO of Monarch Therapeutics)

    Chris Potts

    CEO of Monarch Therapeutics
  • Anne Li (Partner at Crowell & Moring LLP)

    Anne Li

    Partner at Crowell & Moring LLP
  • Kirke Weaver (General Counsel and Corporate Secretary at Organon)

    Kirke Weaver

    General Counsel and Corporate Secretary at Organon
Break
Panel Discussion: Growth Opportunities and Challenges for Life Science Companies in New York
Marc Sedam•David Stockel•Raj Chopra•Lauren Stopfer•Glennis Mehra
  • Marc Sedam (Vice President, Technology Opportunities & Ventures at New York University)

    Marc Sedam

    Vice President, Technology Opportunities & Ventures at New York University
  • David Stockel (Senior Vice President at CBRE, Inc.)

    David Stockel

    Senior Vice President at CBRE, Inc.
  • Raj Chopra (CEO of Aethon Therapeutics)

    Raj Chopra

    CEO of Aethon Therapeutics
  • Lauren Stopfer (Executive Director of Proteomics & Innovation at Aethon Therapeutics)

    Lauren Stopfer

    Executive Director of Proteomics & Innovation at Aethon Therapeutics
  • Glennis Mehra (Managing Director of Biolabs-NYULangone)

    Glennis Mehra

    Managing Director of Biolabs-NYULangone
Fireside Chat
Amy Paulin
  • Amy Paulin (Assemblywoman at New York State Assembly)

    Amy Paulin

    Assemblywoman at New York State Assembly
Break
Fireside Chat
Jonathan Schulhof•Josh Wolfe
  • Jonathan Schulhof (Executive Vice President, Innovation Industries at NYCEDC)

    Jonathan Schulhof

    Executive Vice President, Innovation Industries at NYCEDC
  • Josh Wolfe (Co-founder and Managing Partner of Lux Capital)

    Josh Wolfe

    Co-founder and Managing Partner of Lux Capital
General Session: Connecting investors with the life science startups in our ecosystem
Rana Al-Hallaq•Artavazd Arumov•Tingting Zhang-Kharas•Jonathan Mandelbaum
  • Rana Al-Hallaq (Executive Director and Partner at Pfizer Ventures of Pfizer)

    Rana Al-Hallaq

    Executive Director and Partner at Pfizer Ventures of Pfizer
  • Artavazd Arumov (Principal at Qiming Venture Partners USA)

    Artavazd Arumov

    Principal at Qiming Venture Partners USA
  • Tingting Zhang-Kharas (Head of JLABS US Northeast at Johnson & Johnson Innovation (JLABS))

    Tingting Zhang-Kharas

    Head of JLABS US Northeast at Johnson & Johnson Innovation (JLABS)
  • Jonathan Mandelbaum (Vice President at OrbiMed)

    Jonathan Mandelbaum

    Vice President at OrbiMed
Closing Remarks
Jennifer Hawks Bland
  • Jennifer Hawks Bland (Chief Executive Officer at NewYorkBIO)

    Jennifer Hawks Bland

    Chief Executive Officer at NewYorkBIO
Reception